Core Viewpoint - Huabao Co., Ltd. has publicly committed to avoiding competition with its controlling shareholder, ensuring independent operation and compliance with relevant laws and regulations [1] Group 1 - The controlling shareholder has made a public commitment regarding the avoidance of competition, as detailed in the company's IPO prospectus [1] - The company and its controlling shareholder will continue to strictly adhere to this commitment and relevant legal regulations [1] - A corporate governance supervision mechanism has been established to institutionalize the management of related transactions and controlling shareholder behaviors, safeguarding the legal rights of all shareholders [1] Group 2 - The company will fulfill its information disclosure obligations in a timely manner in accordance with regulatory requirements if any significant matters arise in the future [1]

Core Viewpoint - The company, Huabao Co., Ltd. (300741), is committed to closely monitoring changes in policies and market environments while actively advancing its strategic planning and business expansion [1] Business Strategy - The company focuses on strengthening its industrial chain and upgrading core capabilities, emphasizing the integration of industrial resources through mergers and acquisitions [1] - There is a strong potential for development in the fields of food ingredients and daily chemical fragrances, which the company aims to fully leverage [1] - The company will continue to optimize its operational strategy to enhance overall corporate value [1] Compliance and Disclosure - The company will strictly adhere to regulatory requirements regarding information disclosure, especially in matters related to mergers and acquisitions [1]

Group 1 - The artificial meat concept stocks experienced a short-term surge, with Guoen Co., Ltd. hitting the daily limit up [1] - Fuxiang Pharmaceutical saw an increase of over 15% [1] - Other companies such as Huabao Co., Haoxiangni, Shuanghui Development, Chengzhi Co., and Chunxue Food also experienced gains [1]

Group 1 - Yinghuate will distribute a cash dividend of 0.8 yuan (including tax) for every 10 shares, with the record date on November 13, 2025, and the ex-dividend date on November 14, 2025 [1] - Maihe will distribute a cash dividend of 0.7 yuan (including tax) for every 10 shares, with the record date on November 12, 2025, and the ex-dividend date on November 13, 2025 [1] - Yueda Investment will distribute a cash dividend of 0.03 yuan (including tax) per share, with the record date on November 12, 2025, and the ex-dividend date on November 13, 2025 [1] Group 2 - Huabao will distribute a cash dividend of 0.5 yuan (including tax) for every 10 shares, with the record date on November 12, 2025, and the ex-dividend date on November 13, 2025 [2]

Core Points - Huabao Co., Ltd. announced a cash dividend distribution plan for the third quarter of 2025, proposing a payout of 0.5 RMB per 10 shares (including tax) [2] - The record date for the dividend distribution is set for November 12, 2025, while the ex-dividend date is November 13, 2025 [2]

Core Viewpoint - The company emphasizes its commitment to independent innovation and has a significant number of patents, which reflects its ongoing research and development efforts [1] Patent and R&D Summary - As of June 30, 2025, the company holds a total of 316 patents, including 176 invention patents, 134 utility model patents, and 6 design patents [1] - The company acknowledges that the patent application process involves certain time delays, which may not immediately reflect the outcomes of its R&D efforts [1] - For core technologies that are not suitable for public patent applications, the company employs trade secrets and has established strict internal management and confidentiality mechanisms [1] R&D Mechanisms - The company has developed a comprehensive mechanism for project initiation and the transformation of research results, which continuously promotes the output and industrial application of R&D achievements [1] - The company adheres to accounting standards and information disclosure regulations, ensuring that detailed information regarding patent numbers and R&D expenditures is available in its periodic reports [1]

证券代码：300741 证券简称：华宝股份 公告编号：2025-047 华宝香精股份有限公司 2025年第三季度权益分派实施公告 本公司及董事会全体成员保证公告内容不存在虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、股东大会授权及董事会审议通过权益分派方案情况 1、华宝香精股份有限公司（以下简称"公司"或"本公司"）于 2025 年 4 月 18 日召开 2024 年度股东大会，审议通过了《关于 2025 年中期现金分红规划 的议案》，公司拟在满足《公司章程》规定的现金分红具体条件，且不影响公司 正常经营和持续发展的情况下，进行 2025 年度中期现金分红，现金分红金额不 超过当期归属于上市公司股东净利润的 100%，授权董事会在符合利润分配条件 下，制定具体的中期分红方案。 4、本次实施的分派方案与董事会审议通过的分派方案一致。 5、本次实施分派方案距离董事会审议通过的时间未超过两个月。 二、权益分派方案 本公司2025年第三季度权益分派方案为：以公司现有总股本615,880,000股为 基数，向全体股东每10股派0.500000元人民币现金（含税；扣税后， ...

Core Viewpoint - The company is currently in the construction phase of its food technology comprehensive base in Indonesia, which is expected to provide stable and reliable product support for emerging markets in Southeast Asia and beyond [2]. Group 1: Project Status - The Indonesian project officially broke ground in May 2025 and is still under construction [2]. - The company has not yet obtained all local production licenses or commenced bulk supply as of the latest update [2]. Group 2: Market Impact - Once operational, the project aims to serve ASEAN and overseas consumer groups, enhancing product availability and technical support in emerging markets [2]. - The company will adhere to regulatory requirements for timely information disclosure regarding project progress [2].

华宝香精股份有限公司 信息披露暂缓与豁免业务管理制度 第一章 总则 第一条 为规范华宝香精股份有限公司（以下简称"公司"）和其他信息披 露义务人信息披露暂缓、豁免行为，确保公司依法合规履行信息披露义务，保护 投资者的合法权益，根据《中华人民共和国保守国家秘密法》《中华人民共和国 证券法》《上市公司信息披露管理办法》《上市公司信息披露暂缓与豁免管理规 定》等相关法律法规，并根据《公司章程》及公司《信息披露与投资者关系管理 制度》等有关规定，特制定本制度。 第二条 公司和其他信息披露义务人暂缓、豁免披露临时报告，在定期报告、 临时报告中豁免披露中国证券监督管理委员会和证券交易所规定或者要求披露的 内容，适用本制度。 第三条 公司和其他信息披露义务人应当真实、准确、完整、及时、公平地 披露信息，不得滥用暂缓或者豁免披露规避信息披露义务、误导投资者，不得实 施内幕交易、操纵市场等违法行为。 第四条 公司和其他信息披露义务人应当审慎确定信息披露暂缓、豁免事项， 履行内部审核程序后实施。 暂缓、豁免事项的范围原则上应当与公司股票首次在证券交易所上市时保持 一致，在上市后拟增加暂缓、豁免披露事项的，应当有确实充分的证据。 ...

第一条 为了进一步规范华宝香精股份有限公司（以下简称"公司"）董 事会的议事方式和决策程序，促使董事会和董事落实股东会决议，有效地履行 其职责，提高董事会规范运作和科学决策水平，根据《公司法》等法律、法规、 规范性文件及《公司章程》的相关规定，制定本规则。 第二条 董事会下设董事会办公室（以下称"董事会日常办事机构"）， 处理董事会及董事会各专门委员会的日常事务。董事会日常办事机构由董事会 秘书负责领导。 第三条 董事会定期会议由董事长负责召集。在发出召开董事会定期会 议的通知前，董事会日常办事机构应当充分征求各董事的意见，初步形成会议 提案后交董事长拟定。 董事长在拟定提案前，应当视需要征求公司总裁和其他高级管理人员的意 见。 第四条 《公司章程》规定有权提议召开董事会临时会议的提议人，应 当通过董事会日常办事机构或者直接向董事长提交经提议人签字（盖章）的召 开董事会临时会议的书面提议（董事长就董事会日常职权范围内事项提议召开 的除外）。书面提议中应当载明下列事项： 华宝香精股份有限公司 董事会议事规则 第五条 董事会日常办事机构在收到上述书面提议和有关材料后，应当 于当日立即通知董事长。董事长认为提案内容 ...